ImmunoPrecise Antibodies News

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 28 13:30 ET

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 20 12:07 ET

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

Mar 14 08:24 ET

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

Mar 14 08:03 ET

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Mar 7 11:20 ET

ImmunoPrecise Antibodies | SC 13G: Statement of acquisition of beneficial ownership by individuals-INGALLS & SNYDER LLC(5.01%)

Feb 27 10:36 ET

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

Feb 23 17:36 ET

ImmunoPrecise Antibodies | 424B5: Prospectus

Feb 23 17:31 ET

ImmunoPrecise Antibodies | 6-K/A: Report of foreign private issuer (related to financial reporting)

Feb 15 15:18 ET

ImmunoPrecise Antibodies | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Charmquark TWEE(6.28%),Charmquark EEN(6.28%)

Jan 10 00:00 ET

ImmunoPrecise Antibodies | SC 13G: Statement of acquisition of beneficial ownership by individuals-Charmquark TWEE(6.40%),Charmquark EEN(6.40%)

Jan 10 00:00 ET

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 14, 2023 08:48 ET

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

Dec 14, 2023 08:38 ET

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

Dec 14, 2023 08:03 ET

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 8, 2023 17:11 ET

ImmunoPrecise Antibodies | 424B5: Prospectus

Dec 7, 2023 16:53 ET

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

Dec 6, 2023 17:19 ET

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 6, 2023 07:57 ET

ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

Dec 6, 2023 06:01 ET

ImmunoPrecise Antibodies | 424B5: Prospectus

Dec 5, 2023 16:02 ET